β-ionone induces cell cycle arrest and apoptosis in human prostate tumor cells

Nutrition and Cancer

Volumn 65, Issue 4, 2013, Pages 600-610

  Jones, Sheila ^a   Fernandes, Nicolle V ^a   Yeganehjoo, Hoda ^a   Katuru, Rajasekhar ^a   Qu, Haibin ^b   Yu, Zhiling ^c   Mo, Huanbiao ^a  

^a TEXAS WOMAN'S UNIVERSITY   (United States)

^b ZHEJIANG UNIVERSITY   (China)

^c HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYCHOLESTEROL; BETA IONONE; CYCLIN D1; CYCLIN DEPENDENT KINASE 4; FARNESOL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; MEVALONATE KINASE; MEVINOLIN;

ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CONTROLLED STUDY; DOWN REGULATION; DRUG POTENTIATION; ENZYME DEGRADATION; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; G1 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; NICK END LABELING; PROSTATE CARCINOMA; WESTERN BLOTTING;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; CARCINOMA; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; FARNESOL; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INHIBITORY CONCENTRATION 50; MALE; NORISOPRENOIDS; PROSTATIC NEOPLASMS;

EID: 84877975836     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2013.776091     Document Type: Article

References (56)

1. Hutchison, C J, Bridger, J M, Cox, L S, and, Kill, I R. 1994. Weaving a pattern from disparate threads: lamin function in nuclear assembly and DNA replication. J Cell Sci, 107: 3259-3269.
2. Moir, R D, Spann, T P, Lopez-Soler, R I, Yoon, M, Goldman, A E. 2000. Review: the dynamics of the nuclear lamins during the cell cycle-relationship between structure and function. J Struct Biol, 129: 324-334.
3. Gelb, M H. 1997. Protein prenylation, et cetera: signal transduction in two dimensions. Science, 275: 1750-1751.
4. Zhang, F L, and, Casey, P J. 1996. Protein prenylation: molecular mechanisms and functional consequences. Annu Rev Biochem, 65: 241-269.
5. Elson, C E, Peffley, D M, Hentosh, P, and, Mo, H. 1999. Isoprenoid-mediated inhibition of mevalonate synthesis: potential application to cancer. Proc Soc Exp Biol Med, 221: 294-311.
6. Goldstein, J L, and, Brown, M S. 1990. Regulation of the mevalonate pathway. Nature, 343: 425-430.
7. Goldstein, J L, DeBose-Boyd, R A, and, Brown, M S. 2006. Protein sensors for membrane sterols. Cell, 124: 35-46.
8. Chen, Y, and, Hughes-Fulford, M. 2001. Human prostate cancer cells lack feedback regulation of low-density lipoprotein receptor and its regulator, SREBP2. Int J Cancer, 91: 41-45.
9. Wyss, A. 2004. Carotene oxygenases: a new family of double bond cleavage enzymes. J Nutr, 134: 246S-250S.
10. Yu, S G, Abuirmeileh, N M, Qureshi, A A, and, Elson, C E. 1994. Dietary β-ionone suppresses hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase activity. J Agric Food Chem, 42: 1493-1496.
11. Elson, C E, and, Qureshi, A A. 1995. Coupling the cholesterol- and tumor-suppressive actions of palm oil to the impact of its minor constituents on 3-hydroxy-3-methylglutaryl coenzyme A reductase activity. Prostaglandins Leukot Essent Fatty Acids, 52: 205-207.
12. Mo, H, and, Elson, C E. 1999. Apoptosis and cell-cycle arrest in human and murine tumor cells are initiated by isoprenoids. J Nutr, 129: 804-813.
13. Duncan, R E, Lau, D, El-Sohemy, A, and, Archer, M C. 2004. Geraniol and β-ionone inhibit proliferation, cell cycle progression, and cyclin-dependent kinase 2 activity in MCF-7 breast cancer cells independent of effects on HMG-CoA reductase activity. Biochem Pharmacol, 68: 1739-1747.
14. Janakiram, N B, Cooma, I, Mohammed, A, Steele, V E, and, Rao, C V. 2008. β-Ionone inhibits colonic aberrant crypt foci formation in rats, suppresses cell growth, and induces retinoid X receptor-α in human colon cancer cells. Mol Cancer Ther, 7: 181-190.
15. Liu, J R, Chen, B Q, Yang, B F, Dong, H W, Sun, C H. 2004. Apoptosis of human gastric adenocarcinoma cells induced by β-ionone. World J Gastroenterol, 10: 348-351.
16. Hu, X, White, K M, Jacobsen, N E, Mangelsdorf, D J, and, Canfield, L M. 1998. Inhibition of growth and cholesterol synthesis in breast cancer cells by oxidation products of β-carotene. J Nutr Biochem, 9: 567-574.
17. He, L, Mo, H, Hadisusilo, S, Qureshi, A A, and, Elson, C E. 1997. Isoprenoids suppress the growth of murine B16 melanomas in vitro and in vivo. J Nutr, 127: 668-674.
18. Yu, S G, Anderson, P J, and, Elson, C E. 1995. Efficacy of β-ionone in the chemoprevention of rat mammary carcinogenesis. J Agri Food Chem, 43: 2144-2147.
19. Liu, J R, Sun, X R, Dong, H W, Sun, C H, Sun, W G, Chen, B Q. 2008. β-Ionone suppresses mammary carcinogenesis, proliferative activity and induces apoptosis in the mammary gland of the Sprague-Dawley rat. Int J Cancer, 122: 2689-2698.
20. de Moura Espindola, R, Mazzantini, R P, Ong, T P, de Conti, A, Heidor, R. 2005. Geranylgeraniol and β-ionone inhibit hepatic preneoplastic lesions, cell proliferation, total plasma cholesterol and DNA damage during the initial phases of hepatocarcinogenesis, but only the former inhibits NF-κB activation. Carcinogenesis, 26: 1091-1099.
21. Cardozo, M T, de Conti, A, Ong, T P, Scolastici, C, Purgatto, E. 2011. Chemopreventive effects of β-ionone and geraniol during rat hepatocarcinogenesis promotion: distinct actions on cell proliferation, apoptosis, HMGCoA reductase, and RhoA. J Nutr Biochem, 22: 130-135.
22. Correll, C C, Ng, L, and, Edwards, P A. 1994. Identification of farnesol as the non-sterol derivative of mevalonic acid required for the accelerated degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase. J Biol Chem, 269: 17390-17393.
23. Fernandes, N, Jung, M, Daoud, A, and, Mo, H. 2008. Biphenylalkylacetylhydroquinone ethers suppress the proliferation of murine B16 melanoma cells. Anticancer Res, 28: 1005-1012.
24. Fernandes, N V, Guntipalli, P K, and, Mo, H. 2010. d -δ- Tocotrienol-mediated cell cycle arrest and apoptosis in human melanoma cells. Anticancer Res, 30: 4937-4944.
25. Andree, H A, Reutelingsperger, C P, Hauptmann, R, Hemker, H C, Hermens, W T. 1990. Binding of vascular anticoagulant alpha (VAC alpha) to planar phospholipid bilayers. J Biol Chem, 265: 4923-4928.
26. Fadok, V A, Voelker, D R, Campbell, P A, Cohen, J J, Bratton, D L. 1992. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol, 148: 2207-2216.
27. Sever, N, Yang, T, Brown, M S, Goldstein, J L, and, DeBose-Boyd, R A. 2003. Accelerated degradation of HMG CoA reductase mediated by binding of insig-1 to its sterol-sensing domain. Mol Cell, 11: 25-33.
28. McAnally, J A, Gupta, J, Sodhani, S, Bravo, L, and, Mo, H. 2007. Tocotrienols potentiate lovastatin-mediated growth suppression in vitro and in vivo. Exp Biol Med (Maywood, NJ), 232: 523-531.
29. Massague, J. 2004. G1 cell-cycle control and cancer. Nature, 432: 298-306.
30. DeBose-Boyd, R A. 2008. Feedback regulation of cholesterol synthesis: sterol-accelerated ubiquitination and degradation of HMG CoA reductase. Cell Res, 18: 609-621.
31. Tatman, D, and, Mo, H. 2002. Volatile isoprenoid constituents of fruits, vegetables and herbs cumulatively suppress the proliferation of murine B16 melanoma and human HL-60 leukemia cells. Cancer Lett, 175: 129-139.
32. Wattenberg, L W, Loub, W D, Lam, L K, and, Speier, J L. 1976. Dietary constituents altering the responses to chemical carcinogens. Fed Proc, 35: 1327-1331.
33. Elson, C E. 1995. Suppression of mevalonate pathway activities by dietary isoprenoids: protective roles in cancer and cardiovascular disease. J Nutr, 125: 1666S-1672S.
34. Prasanna, P, Thibault, A, Liu, L, and, Samid, D. 1996. Lipid metabolism as a target for brain cancer therapy: synergistic activity of lovastatin and sodium phenylacetate against human glioma cells. J Neurochem, 66: 710-716.
35. Repa, J J, Hanson, K K, and, Clagett-Dame, M. 1993. All-trans-retinol is a ligand for the retinoic acid receptors. Proc Natl Acad Sci USA, 90: 7293-7297.
36. Srivastava, J K, and, Gupta, S. 2006. Tocotrienol-rich fraction of palm oil induces cell cycle arrest and apoptosis selectively in human prostate cancer cells. Biochem Biophys Res Commun, 346: 447-453.
37. Mo, H, and, Elson, C E. 2004. Studies of the isoprenoid-mediated inhibition of mevalonate synthesis applied to cancer chemotherapy and chemoprevention. Exp Biol Med (Maywood), 229: 567-585.
38. Lee, S J, Ha, M J, Lee, J, Nguyen, P, Choi, Y H. 1998. Inhibition of the 3-hydroxy-3-methylglutaryl-coenzyme A reductase pathway induces p53-independent transcriptional regulation of p21(WAF1/CIP1) in human prostate carcinoma cells. J Biol Chem, 273: 10618-10623.
39. Bennis, F, Favre, G, Le Gaillard, F, and, Soula, G. 1993. Importance of mevalonate-derived products in the control of HMG-CoA reductase activity and growth of human lung adenocarcinoma cell line A549. Int J Cancer, 55: 640-645.
40. Kawata, S, Takaishi, K, Nagase, T, Ito, N, Matsuda, Y. 1990. Increase in the active form of 3-hydroxy-3-methylglutaryl coenzyme A reductase in human hepatocellular carcinoma: possible mechanism for alteration of cholesterol biosynthesis. Cancer Res, 50: 3270-3273.
41. El-Sohemy, A, and, Archer, M C. 2000. Inhibition of N-methyl-N- nitrosourea- and 7,12-dimethylbenz[a] anthracene-induced rat mammary tumorigenesis by dietary cholesterol is independent of Ha-Ras mutations. Carcinogenesis, 21: 827-831.
42. Harwood, H J Jr., Alvarez, I M, Noyes, W D, and, Stacpoole, P W. 1991. In vivo regulation of human leukocyte 3-hydroxy-3-methylglutaryl coenzyme A reductase: increased enzyme protein concentration and catalytic efficiency in human leukemia and lymphoma. J Lipid Res, 32: 1237-1252.
43. Caruso, M G, Notarnicola, M, Cavallini, A, and, Di Leo, A. 2002. 3-Hydroxy-3-methylglutaryl coenzyme A reductase activity and low-density lipoprotein receptor expression in diffuse-type and intestinal-type human gastric cancer. J Gastroenterol, 37: 504-508.
44. Hentosh, P, Yuh, S H, Elson, C E, and, Peffley, D M. 2001. Sterol-independent regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in tumor cells. Mol Carcinog, 32: 154-166.
45. Peffley, D M, Mo, H, Gayen, A K, and, Elson, C E. 1998. Functional consequences of the modulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity by isoprenoids. Proc Am Assoc Cancer Res (abstr), 39. 312A
46. Peffley, D M, and, Gayen, A K. 2003. Plant-derived monoterpenes suppress hamster kidney cell 3-hydroxy-3-methylglutaryl coenzyme a reductase synthesis at the post-transcriptional level. J Nutr, 133: 38-44.
47. Case, G L, He, L, Mo, H, and, Elson, C E. 1995. Induction of geranyl pyrophosphate pyrophosphatase activity by cholesterol-suppressive isoprenoids. Lipids, 30: 357-359.
48. Mahattanatawee, K, Rouseff, R, Valim, M F, and, Naim, M. 2005. Identification and aroma impact of norisoprenoids in orange juice. J Agric Food Chem, 53: 393-397.
49. Crowell, P L, and, Elson, C E. 2001. " Isoprenoids, health and disease ". In Handbook of Nutraceuticals and Functional Foods CRC Series in Modern Nutrition, Edited by: Wildman, R EC. 31-53. Boca Raton, FL: CRC Press.
50. Plotto, A, Barnes, K W, and, Goodner, K L. 2006. Specific anosmia observed for β-ionone, but not for α-ionone: significance for flavor research. J Food Sci, 71: S401-S406.
51. Suyama, K, Yeow, T, and, Nakai, S. 1983. Vitamin A oxidation products responsible for haylike flavor production in nonfat dry milk. J Agric Food Chem, 31: 22-26.
52. Lalko, J, Lapczynski, A, McGinty, D, Bhatia, S, Letizia, C S. 2007. Fragrance material review on β-ionone. Food Chem Toxicol, 45: S241-S247.
53. Ide, H, and, Toki, S. 1970. Metabolism of β-ionone. Isolation, characterization and identification of the metabolitesin the urine of rabbits. Biochem J, 119: 281-287.
54. Kirsh, V A, Peters, U, Mayne, S T, Subar, A F, Chatterjee, N. 2007. Prospective study of fruit and vegetable intake and risk of prostate cancer. J Natl Cancer Inst, 99: 1200-1209.
55. Jung, M, Mo, H, and, Elson, C E. 1998. Synthesis and biological activity of β-ionone-derived alcohols for cancer chemoprevention. Anticancer Res, 18: 189-192.
56. Zhou, J, Geng, G, Batist, G, and, Wu, J H. 2009. Syntheses and potential anti-prostate cancer activities of ionone-based chalcones. Bioorg Med Chem Lett, 19: 1183-1186.